Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 32.20M | 37.92M | 34.78M | 30.79M | 28.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.57M | 72.37M | 66.06M | 55.19M | 50.28M |
| Operating Income | -72.57M | -72.37M | -66.06M | -55.19M | -50.28M |
| Income Before Tax | -65.10M | -67.76M | -62.10M | -52.40M | -47.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.10 | -67.76 | -62.10 | -52.40 | -47.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -65.10M | -67.76M | -62.10M | -52.40M | -47.25M |
| EBIT | -72.57M | -72.37M | -66.06M | -55.19M | -50.28M |
| EBITDA | -72.53M | -72.34M | -66.05M | -46.80M | -31.07M |
| EPS Basic | -0.67 | -0.72 | -0.72 | -0.55 | -0.58 |
| Normalized Basic EPS | -0.44 | -0.47 | -0.45 | -0.43 | -0.45 |
| EPS Diluted | -0.67 | -0.72 | -0.72 | -0.55 | -0.58 |
| Normalized Diluted EPS | -0.44 | -0.47 | -0.45 | -0.43 | -0.45 |
| Average Basic Shares Outstanding | 372.77M | 365.54M | 346.19M | 300.15M | 256.25M |
| Average Diluted Shares Outstanding | 372.77M | 365.54M | 346.19M | 300.15M | 256.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |